Skip to main content

Global Point of Care Diagnostics Market to Rise at 6.6% CAGR to Reach US$ 28,379.6 Mn by 2026, Increasing Disposable Incomes of People Worldwide Promoting Growth, says Fortune Business Insights

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, Sept. 02, 2020 (GLOBE NEWSWIRE) — According to the report, the Point of Care Diagnostics Market is anticipated to reach US$ 28,379.6 Mn by the end of 2026 from US$ 17,019.5 Mn in 2018. The forecast period is set from 2018 to 2026 and the market is expected to grow at a CAGR of 6.6%.The increasing awareness about importance of proper infrastructure in healthcare settings is boosting the global market, predicts Fortune Business Insights in their new report. The report is titled,” Point-of-care Diagnostics (POC) Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2026”.Highlights of the Report:•              Analysis of the impact of Covid-19 that the market would face in the near future.
•              In-depth analysis of the growth drivers and obstacles.
•              Profile of all the companies operating in the market.
•              Elaborate data about the dominating region.
•              Competitive landscape consisting of mergers & acquisitions, investments, partnerships, new product launches, opening of new facilities, and new contracts.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/point-of-care-diagnostics-market-101072
Increasing Need for Immunotherapy and Other Therapeutic Methods to Promote GrowthThe rise in geriatric population and their vulnerability towards various are augmenting growth of the global point-of-care diagnostic market. This, coupled with the rising prevalence of infectious diseases, is boosting the market. The rise in disposable income of people worldwide has encouraged them to opt for better healthcare treatment and facilities. This is further prognosticated to fuel the demand for Point of Care Diagnostics Market in the coming years.Furthermore, rising incidence of target diseases is propelling the demand for point-of-care diagnostic methods. Such factors are anticipated to help the market generate better revenue in the years to come.However, factors such as high cost of installation and high maintenance costs may hamper the market in the long run. Nevertheless, with advancement in technology and new product launches, the market is anticipated to grow remarkably in the years to come.The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/point-of-care-diagnostics-market-101072
Asia Pacific to Emerge as Fastest Growing Region Backed by Improving Healthcare SettingsFortune Business Insights foresees the global market for point-of-care diagnostics to witness the dominance of North America owing to the increasing demand for technologically advanced point-of-care (POC) diagnostic products that provided accurate results. As per Fortune Business Insights, the North America market was valued at US$ 6,125.5 Mn in 2018. However, the rapidly increasing and improving healthcare infrastructure in emerging economies of Asia Pacific such as China and India may help the region to emerge as the fastest growing region in the forecast duration.Some of the key players operating in the global Point of Care Diagnostics Market:F. Hoffmann-La Roche LtdJohnson & Johnson Services, Inc.Dickinson and Company (BD)Sekisui DiagnosticsInstrumentation Laboratory (A Werfen Company)Chembio Diagnostic Systems, Inc.AccuBioTech Co., Ltd.Siemens Healthcare GmbHPTS DiagnosticsDanaherNova BiomedicalQuidel CorporationEKF Diagnostics Holdings plcBecton
Quick Buy –  Point of Care Diagnostics Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101072
Point of Care Diagnostics Market Segmentations:By Product           •              Blood Glucose Monitoring•              Infectious Diseases•              Cardiometabolic Diseases•              Pregnancy and Fertility Testing Products•              Hematology Testing Products•              OthersBy End User         •              Hospitals Bedside•              Physician’s Office Lab•              Urgent Care & Retail Clinics•              Home and Self TestingBy Geography      •              North America (the USA and Canada)•              Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)•              Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)•              Latin America (Brazil, Mexico and Rest of Latin America)•              Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/point-of-care-diagnostics-market-101072
Have a Look at Related Reports:Medical Devices Market Share and Global Trend By Type (Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, IVD, MIS, Wound Management, Diabetes Care, Ophthalmic Devices, Dental & Nephrology), End User (Hospitals & Ambulatory Surgical Centers and Clinics) and Geography Forecast till 2025Molecular Diagnostics Market Share and Global Trend By Product Type (Instruments Reagents & Consumables), Application (Infectious Disease, Blood Screening, Histology & Oncology), Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs) and Geography Forecast till 2025Immunodiagnostics Market Share and Global Trend By Product Instruments, Reagents & Consumables), By Application (Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases), By End user (Clinical Laboratories, Hospitals, Physician’s Offices), By End-user(Hospitals, Dental Clinics, Academic & Research Institutes) and Geography Forecast till 2026In-vitro Diagnostics (IVD) Market Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Point of Care, Hematology and Others), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Others), By End User (Clinical Laboratories, Hospitals, Physicians Offices, Others) and Regional Forecast, 2019 – 2026
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/point-of-care-diagnostics-market-9219

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.